These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 24115839)
1. 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications. Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V Drug Des Devel Ther; 2013; 7():1157-78. PubMed ID: 24115839 [TBL] [Abstract][Full Text] [Related]
2. A chelating agent possessing cytotoxicity and antimicrobial activity: 7-morpholinomethyl-8-hydroxyquinoline. Shen AY; Chen CP; Roffler S Life Sci; 1999; 64(9):813-25. PubMed ID: 10075114 [TBL] [Abstract][Full Text] [Related]
3. Metal ions, Alzheimer's disease and chelation therapy. Budimir A Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339 [TBL] [Abstract][Full Text] [Related]
4. 8-Hydroxyquinolines in medicinal chemistry: A structural perspective. Oliveri V; Vecchio G Eur J Med Chem; 2016 Sep; 120():252-74. PubMed ID: 27191619 [TBL] [Abstract][Full Text] [Related]
5. A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. Cacciatore I; Cornacchia C; Fornasari E; Baldassarre L; Pinnen F; Sozio P; Di Stefano A; Marinelli L; Dean A; Fulle S; Di Filippo ES; La Rovere RM; Patruno A; Ferrone A; Di Marco V ChemMedChem; 2013 Nov; 8(11):1818-29. PubMed ID: 24106097 [TBL] [Abstract][Full Text] [Related]
7. Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring. Scheibel LW; Adler A Mol Pharmacol; 1982 Jul; 22(1):140-4. PubMed ID: 6811856 [No Abstract] [Full Text] [Related]
8. Nitric oxide-donating and reactive oxygen species-responsive prochelators based on 8-hydroxyquinoline as anticancer agents. Zhang Y; Yang J; Meng T; Qin Y; Li T; Fu J; Yin J Eur J Med Chem; 2021 Feb; 212():113153. PubMed ID: 33453603 [TBL] [Abstract][Full Text] [Related]
9. 8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis. Shah S; Dalecki AG; Malalasekera AP; Crawford CL; Michalek SM; Kutsch O; Sun J; Bossmann SH; Wolschendorf F Antimicrob Agents Chemother; 2016 Oct; 60(10):5765-76. PubMed ID: 27431227 [TBL] [Abstract][Full Text] [Related]
10. Drug design strategies with metal-hydroxyquinoline complexes. Savić-Gajić IM; Savić IM Expert Opin Drug Discov; 2020 Mar; 15(3):383-390. PubMed ID: 31829757 [No Abstract] [Full Text] [Related]
11. Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer's disease. Yang X; Cai P; Liu Q; Wu J; Yin Y; Wang X; Kong L Bioorg Med Chem; 2018 Jul; 26(12):3191-3201. PubMed ID: 29729985 [TBL] [Abstract][Full Text] [Related]
12. Insights of 8-hydroxyquinolines: A novel target in medicinal chemistry. Gupta R; Luxami V; Paul K Bioorg Chem; 2021 Mar; 108():104633. PubMed ID: 33513476 [TBL] [Abstract][Full Text] [Related]
13. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. Fernández-Bachiller MI; Pérez C; González-Muñoz GC; Conde S; López MG; Villarroya M; García AG; Rodríguez-Franco MI J Med Chem; 2010 Jul; 53(13):4927-37. PubMed ID: 20545360 [TBL] [Abstract][Full Text] [Related]
14. Multifunctional 8-hydroxyquinoline-appended cyclodextrins as new inhibitors of metal-induced protein aggregation. Oliveri V; Attanasio F; Puglisi A; Spencer J; Sgarlata C; Vecchio G Chemistry; 2014 Jul; 20(29):8954-64. PubMed ID: 24863958 [TBL] [Abstract][Full Text] [Related]
15. Antioxidant Properties and the Formation of Iron Coordination Complexes of 8-Hydroxyquinoline. Chobot V; Hadacek F; Bachmann G; Weckwerth W; Kubicova L Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544490 [TBL] [Abstract][Full Text] [Related]
16. Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease. Knez D; Sosič I; Pišlar A; Mitrović A; Jukič M; Kos J; Gobec S Curr Alzheimer Res; 2019; 16(9):801-814. PubMed ID: 31660830 [TBL] [Abstract][Full Text] [Related]
17. New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations. Fu CL; Hsu LS; Liao YF; Hu MK Arch Pharm (Weinheim); 2016 May; 349(5):327-41. PubMed ID: 27027880 [TBL] [Abstract][Full Text] [Related]
19. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy. Zheng H; Youdim MB; Fridkin M J Med Chem; 2009 Jul; 52(14):4095-8. PubMed ID: 19485411 [TBL] [Abstract][Full Text] [Related]
20. PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study. Summers KL; Dolgova NV; Gagnon KB; Sopasis GJ; James AK; Lai B; Sylvain NJ; Harris HH; Nichol HK; George GN; Pickering IJ Metallomics; 2020 Dec; 12(12):1979-1994. PubMed ID: 33169753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]